Just not fare – bus passengers losing out on the Costa Blanca

SAME PRICE: Alsa bus passengers are not feeling the benefit of the scrapping of the AP-7 tolls CREDIT: Ayuntamiento Cartagena

THE scrapping of tolls on the AP-7 between Alicante and Tarragona is a reality and benefits general motorists, but public transport passengers are still feeling the pinch.
Ticket prices for the intercity bus service that connects the Marina Alta with Valencia and Alicante, managed by the Alsa company, remains the same, despite the firm not having to pay to use the road.
The regular price from Denia to Valencia is still €11.50 euros – excluding any of the occasional discounts – and to Alicante, €11.80 euros. From Javea its €12.45 and €10.55 respectively.
The company increased these prices in the middle of last year by 1.5 per cent. But now, the savings on the AP-7 is not reflected, claims a report by the Court of Defence of Competition.
It states that the elimination of tolls has ‘simply brought a benefit for the company but not for the passenger’.
According to Spanish press reports, Alsa responded by saying it has ‘struggled’ but endeavoured to provide at least the main towns in the region with more direct services to the big cities.

Author badge placeholder
Written by

Tara Rippin

Tara Rippin is a reporter for Spain’s largest English-speaking newspaper, Euro Weekly News, and is responsible for the Costa Blanca region.
She has been in journalism for more than 20 years, having worked for local newspapers in the Midlands, UK, before relocating to Spain in 1990.
Since arriving, the mother-of-one has made her home on the Costa Blanca, while spending 18 months at the EWN head office in Fuengirola on the Costa del Sol.
She loves being part of a community that has a wonderful expat and Spanish mix, and strives to bring the latest and most relevant news to EWN’s loyal and valued readers.

Share your story with us by emailing newsdesk@euroweeklynews.com, by calling +34 951 38 61 61 or by messaging our Facebook page www.facebook.com/EuroWeeklyNews

Comments